Primary Image

violet background with white rectangles

Clinical Trial

Effects of twice-daily dosing 4-AP on Functional Recovery after Spinal Cord Injury

IRB Protocol Number STU00221545

Contact

Bing Chen bchen03@sralab.org

Objective

Our studies aim to investigate potential Neuro-modulation Therapies with the help of an FDA approved drug in individuals with spinal cord injuries

Your participation will involve a non-invasive, and painless way to stimulate persons with spinal cord injuries, while muscle activity is observed and recorded.

Participants could participate in trials involving:

  • Non-invasive Brain Stimulation
  • Spinal Cord Stimulation
  • Exercise Training
  • Flexible Schedules

Who Can Participate

  • Spinal cord injury between C2–L2  
  • At least 6 months post-injury
  • Complete or incomplete
  • Male or female

Compensation

Opportunities for Compensation

Age Range

18-85

Apply for this Trial

Your information will not be published.

All fields are required.

Featured Quote

More Studies

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis (PREDICT)

This is a clinical trial of people who have pain due to knee osteoarthritis at Northwestern University Feinberg School of Medicine in collaboration with Shirley Ryan 小恩雅. The study will last for about 20 weeks. 180 qualified participants will be randomly assigned in a 1:1:1 ratio (60 participants per group) to one of three treatment groups: duloxetine, celecoxib or placebo. Participants will have an X-ray, knee MRI, brain MRI, blood draws, pain sensitivity testing and will be asked to fill out questionnaires. The purpose of this study is to predict which participants will respond to the treatment.

read more
view all

Latest Updates

view all